Comments on the translational and transcriptional origin of Euglena chloroplastic aminoacyl-tRNA synthetases

Autor: L I Hecker, Jerome A. Schiff, Steven D. Schwartzbach, W.E. Barnett, Farrelly Jg

Publikováno v: Archives of microbiology. 109(3)

A response to: “A consideration of Euglena gracilis W3BUL as a cytoplasmic control for the wild-type phenylalanyl-tRNA synthetase system” and “A reinvestigation of the sites of transcription and translation of Euglena chloroplastic phenylalanyl

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::03a094903ecd32c598e3e5775621054a
https://pubmed.ncbi.nlm.nih.gov/825072

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Regulatory perspectives of Type II prodrug development and time-dependent toxicity management: nonclinical Pharm/Tox analysis and the role of comparative toxicology.

Autor: Wu KM; Center for Drug Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Avenue, Silver Spring, MD 20993, United States. kueimeng.wu@fda.hhs.gov, Farrelly JG

Publikováno v: Toxicology [Toxicology] 2007 Jul 01; Vol. 236 (1-2), pp. 1-6. Date of Electronic Publication: 2007 Apr 21.

Regulatory science: a special update from the United States Food and Drug Administration: Preclinical issues and status of investigation of botanical drug products in the United States.

Autor: Wu KM; Center for Drug Evaluation and Research, Food and Drug Administration, Rockville, MD 20852, USA. wuk@cder.fda.gov, DeGeorge JG, Atrakchi A, Barry E, Bigger A, Chen C, Du T, Freed L, Geyer H, Goheer A, Jacobs A, Jean D, Rhee H, Osterberg R, Schmidt W, Farrelly JG

Publikováno v: Toxicology letters [Toxicol Lett] 2000 Jan 05; Vol. 111 (3), pp. 199-202.

Metabolism of the liver carcinogen N-nitrosopyrrolidine by rat liver microsomes.

Autor: Hecker LI, Farrelly JG, Smith JH, Saavedra JE, Lyon PA

Publikováno v: Cancer research [Cancer Res] 1979 Jul; Vol. 39 (7 Pt 1), pp. 2679-86.